Abstract
Although aluminum is one of the most common elements in the biosphere, no normal functions or biochemical reactions are known for this metal. In chemical reactions, the small ionic radius and high charge (r=.51A; charge=3+) results in prolonged dissociation times compared to other biological cations and probably renders aluminum unsuitable or toxic to many biological systems. Nevertheless, many biological organisms have probably evolved in the presence of considerable concentrations of bioavailable aluminum and appear to have developed either a tolerance or an effective mechanism for exclusion of aluminum from intracellular reactions. Healthy mammalian brain, for instance, appears to have a well regulated aluminum content ranging between 1.1 and 1.9 µg/g dry weight [1]. Mammalian brain possesses a highly effective membrane barrier at the blood-brain interface. In addition, the brain of some species i.e. rats, mice and the neurologically normal human appear to be able to tolerate considerably higher concentrations of intracellular aluminum than species such as the cat and rabbit. In an aluminum sensitive species mean brain tissue concentrations of 6 to 8 µg/g dry weight are lethal [2, 3]. The species variation in the neurotoxic threshold to aluminum support the hypothesis that the brain of certain species have ligands of high aluminum affinity capable of either detoxifying or partitioning the element into biologically unreactive complexes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Crapper DR, Krishnan SS and Dalton AJ, 1976: Aluminum, neurofibrillary degeneration and Alzheimer’s disease. Brain 99: 67.
Crapper DR and Tomko GS, 1975: Neuronal correlates of an encephalopathy induced by aluminum neurofibrillary degeneration. Brain Res 97: 253.
De Boni U, Otvos A, Scott JW and Crapper DR, 1976: Neurofibrillary degeneration induced by systemic aluminum. Act Neuropathol (Berl) 35: 285.
Crapper DR, Krishnan SS and Dalton AJ, 1973: Brain aluminum distribution of Alzheimer’s disease and experimental neurofibrillary degeneration. Science 180: 511.
Vogt T. 1986. The relationship between aluminum in the drinking water on Alzheimer’s disease in southern Norway. Central Bureau of Statistics. Oslow, Norway.
Jaworski JF, 1986: Aluminum in the human diet. In: Aluminum in the Canadian Environ¬ment. Edited by M. Havas and J.F. Jaworski. Publication No. NRCC 24759 of the Environmental Secretariat. Ottawa, Canada K1A OR6. pp. 175–180.
Jervis GA, 1948: Early senile dementia in mongoloid idiocy. Am J Psych 105: 102.
Malamud N, 1972: Neuropathology of organic brain syndromes associated with aging. In: Gaitz, C.M. (ed.), Advances in Behavioral Biology. New York, Plenum Press Inc., Vol. 2, pp. 63–87.
Crapper DR, Dalton AJ, Skopitz M, Scott VW, Hachinski V, 1975: Alzheimer degeneration in Down Syndrome. Arch Neurol 32: 618.
St. George-Hyslop PH, Tanzi RE, Polinski RJ, Haines JL, et al., 1987: The genetic defect causing familial Alzheimer’s disease maps in chromosome 21. Science (Wash.) 235: 885.
De Boni U, Scott JW, and Crapper DR, 1974: Intracellular aluminum binding: a histochemical study. Histochem 40: 31.
Crapper DR, Quittkat S, Krishnan SS, Dalton AJ and De Boni U, 1980: Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy and experimental aluminum encephalopathy. Acta Neuropathol (Berl) 50: 19.
Perl D and Brody A, 1980: Alzheimer’s disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208: 297.
McLachlan Crapper DR, 1986: Aluminum and Alzheimer’s disease. Neurobiol of Aging 7: 525.
McLachlan Crapper DR, Lukiw WJ and Krück TP A. (In press). Effects of aluminum on gene expression: a possible role in Alzheimer’s disease. In: Khachaturian, S (ed) Aluminum and Other Trace Metals in Alzheimer’s Disease.
Prusiner S, Groth D, Bolton D, Kent S and Hood L, 1985: Purification and structural studies of a major scrapie prion protein. Cell 38: 127.
Oesch B, Westaway D, Walchli M, McKinley M, Kent S, Aebersold R, Barry R, Tempst P, Teplow D, Hood L, Prusiner S and Weissmann C, 1985: A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735.
Glenner GG and Wong CW, 1984: Alzheimer’s disease and Down’s syndrome: sharing of an unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122: 1131.
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL and Beyreuther K, 1985: Amyloid plaque core protein in Alzheimer’s disease and Down’s syndrome. Proc Natl Acad Sci USA 82: 4245.
Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RW and Beyreuther K, 1985: Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood results. EMBO J. 4: 2757.
Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, Bergstrom S, Robbins K, Mayer L, Keith J, Goron C and Haase A, 1985: Identification of scrapie prion protein- specific mRNA in scrapie-injected and uninfected brain. Nature 315: 331.
Traub RD, Rains TC, Garruto RM et al., 1981: Brain destruction alone does not elevate brain aluminum. Neurology (N.Y.) 31: 986.
Glenner GG, Eanes ED, Bladen HA, Linke RP and Termini JD, 1974: B-pleated sheet fibrils: a comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 22: 1141.
Tomlinson BE, Blessed G and Roth M, 1968: Observations on the brains of non-demented old people. J Neurol Sci 7: 331.
Nikaido T, Austin J, Trueb L and Rinehart R, 1972: Studies in aging of the brain. II. Micro-chemical analyses of the nervous system in Alzheimer patients. Arch Neurol 27: 549.
Duckett S and Galle P, 1976: Mise en evidence de l’aluminum dans les plaques de la maladie d’Alzheimer: etudie a la microsonde de Castaing. CR Acad Sci [D] (Paris) 282: 393.
Candy JM, Klinowski J, Perry RH, Perry EK, Fairbairn A, Oakley A, Carpenter T, Atack J, Blessed G and Edwardson J, 1986: Aluminosilicates and senile plaque formation in Alzheimer’s disease. Lancet 1: 354.
Glenner GG, 1979: Congophilic microangiopathy in the pathogenesis of Alzheimer’s syn¬drome (presenile dementia). Med Hypotheses 5: 1231.
Kang J, Lemaire H, Unterbeck A, Salbaum M, Masters CL, Grezeschik K, Multhaup G, Beyreuther K and Muller-Hill B, 1987: The precursor of Alzheimer disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733.
Goldgaber D, Lerman MI, McBude OW, Saffiotti U and Gajdusek DC, 1987: Characterization and chromosonal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science (Wash.) 235: 877.
Tanzi R. Gusella JF, Watkins PC, Bruns GA, St. George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurnit D and Neve R, 1987: Amyloid B protein gene:cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science (Wash.)235: 880.
Esiri M and Williams RJP, 1986: Comments on an olfactory source for an environmental influence and possible involvement of aluminum in the development of Alzheimer’s disease. Neurobiol Aging 7: 582.
Selkoe DJ, 1986: Altered structural proteins in plaques and tangles: What do they tell us about the biology of Alzheimer’s disease. Neurobiol Aging 7: 425.
Sternberger N, Sternberger L and Ulrich J, 1985: Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci USA 82: 4274.
Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski H and Binder LI, 1986: Abnormal phosphorylation of the microtubule-associated protein T (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913.
Kirschner DA, Abraham C and Selkoe DJ, 1986: X-ray diffraction from intra-neuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer’s disease indicates cross-B conformation. Proc Natl Acad Sci USA 83: 503.
Mori H, Kando J and Ihara Y, 1987: Ubiquitin is a component of paired helical filaments in Alzheimer’s disease (Wash.) 235: 1641.
Hershko A, Ciechanover A, Heller H, Haas AL and Rose A, 1980: Proposed role of ATP in protein breakdown: conjugation of proteins with multiple chains of the polypeptide of ATP-dependent proteolysis. Proc Natl Acad Sci USA 77: 1783.
Perl D, Gajdusek D and Garruto R, 1982: Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Guam parkinsonism-dementia of Guam. Science 217: 1053.
Garruto RM, Fukaton R, Yongihara R, Gajdusek DC, Hook G and Fiore C, 1984: Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism- dementia of brain. Proc Natl Acad Sci USA 81: 1875.
Perl D, 1986: The aluminum hypothesis of Alzheimer’s disease: a personal view based on microscopic analysis. Neurobiol Aging 7: 550.
Troncoso J, Sternberger L, Sternberger N, Hoffman and Price D, 1985: Immunocytochemi- cal studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum. J Neuropathol Exp Neurol 44: 332, Abst. No. 77.
Munoz-Garcia D, Pendleburry W, Kessler J and Perl D, 1986: An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles. ACTA Neuropathol (Berl.) 70: 243–248.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Crapper McLachlan, D.R. (1990). Alzheimer’s disease: Aluminum and fibrinous proteins. In: de Broe, M.E., Coburn, J.W. (eds) Aluminum and renal failure. Developments in Nephrology, vol 26. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1868-9_9
Download citation
DOI: https://doi.org/10.1007/978-94-009-1868-9_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7333-2
Online ISBN: 978-94-009-1868-9
eBook Packages: Springer Book Archive